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PLAGUE VACCINES
A report on l iv in g  antip lague vaccin es (v iru s-v a cc in es) was presented at the Fourth 
Congress o f Tropical Medicine by Dr. Georges Girard, Chief o f the Plague Service o f the 
Pasteur In s t itu te  of Paris and former D irector o f  the Pasteur In s t itu te  o f  Madagascar.
Since 1934, liv in g  vaccines have replaced k i l le d  vaccines in the immunization o f man 
again st plague in Madagascar and Java.
Having observed th a t, w hile k il le d  vaccine was in e f fe c t iv e ,  a s in g le  dose o f E. V. 
virus-vaccin e produced a s o lid  and la st in g  immunity in the guinea p ig, Girard and Robic 
carried  out in ocu la tion s of the same vaccine in man in  Madagascar in 1932-1934. Otten made 
sim ila r  observations at the same time in  Java with the T jiv id ej Strain . D ifferen ces in 
immunizing power of these two stra in s  led to  the hypothesis that there are at le a s t  two 
antigens in  these v iru s-vacc in es, one a ctiv e  for the guinea pig, the other for the rat. 
The practical conclusion i s  that, for man, a combination of both stra in s would be d esirab le,
A liv in g  plague vaccine must be innocuous for man, but t h is  can be demonstrated only  
in man. I t  need not be devoid o f a l l  pathogenic power for animals in  order, to  be harm­
le s s  for man, Only by animal inoculation  can a v iru len t s tra in  be d istin gu ish ed  from an 
AVIRULENT stra in . S o-ca lled  AVIRULENT stra in s  are merely stra in s with weakened v iru len ce. 
The v iru len ce may vary according to  the animal used, the method of in ocu lation , and the 
dose. The an tigen ic  p rop erties may become le s s ,  but under natural con d ition s never be­
come greater. An av iru len t s tr a in  may have no an tigen ic power. Each s tr a in  has i t s  own 
in d iv idu al behavior on t h is  point. There is  no su r e -f ir e  method for obtain ing a sta b le  
viru s-vaccin e from a v iru len t stra in . Various methods require varying len gth s o f time.
To be e f f e c t iv e  fo r  man, a v ir u s-v a cc in e  must have the fo llo w in g  c h a r a c te r is t ic s :  
maintenance o f a certa in  degree o f v iru len ce for the guinea pig and p ers isten ce  o f the 
t o x ic i t y  o f  th e m icrobial bodies. Any plague s tr a in  to  be used for  human in ocu la tion  
must be su bject to  regular control. Conservation on n u tr it iv e  gelose, at 2-4°. with an­
nual re in o cu la tio n  has been su cc essfu l for the E, V. s tra in . I t s  c h a r a c te r is t ic s  have 
remained in ta c t for fourteen years. Passage through the guinea p ig, with seeding o f  the 
t is s u e s  of certa in  organs, w ill serve for occasional reinforcement o f antigenic properties.
A liv in g  vaccine must be prepared as needed and cannot be stocked. Because o f the im­
portance o f inocu lating the maximum o f v iab le  b acteria , the period o f v a lid ity  has been 
fixed  a rb itr a r ily  at one month, provided the ampoules are kept under re fr ig era tio n . The 
b a cter ia l content may vary widely according to the stra in  used. A s in g le  dose o f  one cu. 
cc. i s  inoculated. Because k ille d  vaccines can be stocked and quickly controlled , v iru s-  
vaccines should be reserved for stron gly  endemic areas with annual epidemics, where e f ­
f e c t iv e  e t io lo g ic a l  prophylaxis i s  im p ossib le . Mass v a cc in a tio n s  with v ir u s-v a cc in e  
reduces m orbidity by 80%. A booster in ocu lation  i s  advised before the annual epidemic; 
p ro tec tio n  i s  acquired on the f i f t h  day and i s  not preceded by a n ega tive  phase. No 
accid en ts have been reported; reaction s are s l ig h t .
Over seven m illion  human in ocu la tion s have been done in Africa, Asia, and the Ü.S.S.R. 
with various aviru lent s tra in s . Several s tra in s  have been studied in Madagascar and Java 
and others are now being studied  at the G. W. Hooper Foundation.
The r e a c tio n s  produced in  animals by l iv in g  vacc in es in d ica te  that th e p rocess of 
immunity in plague i s  c e llu la r  rather than hormonal. This i s  supported by work done on 
th e d efense mechanism o f the lung fo llow in g  in h a la tion  o f v ir u s-v a c c in e s , which a lso  
su ggests the p o s s ib i l i t y  o f a more e f f e c t iv e  p rotection  against plague pneumonia. Work 
in progress on the antigens o f  P. pest is and the iso la t io n  o f severa l fraction s, one o f  
which p r o te c ts  the guinea p ig , may lead to  g rea ter  ch oice o f v a cc in a l s tr a in s , and, 
perhaps, to  eventual su b stitu tio n  o f  chemical antigens for the present vaccin es. U ntil 
then, v ir u s-v a cc in e  represents a proved method o f  plague prevention which has already  
spared many l iv e s  in A frica  and Asia.
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